 | Up a level |
Number of items: 1.
Johnson, M. L., Gort, E., Pant, S., Lolkema, M. P., Sebastian, M., Scheffler, M., Hwang, J., Duenzinger, U., Riemann, K., Kitzing, T. and Janne, P. A. (2021). A phase I, open-label, dose-escalation trial of BI 1701963 in patients (pts) with KRAS mutated solid tumours: A snapshot analysis. Ann. Oncol., 32. S. S591 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041